# SIPA1

## Overview
SIPA1, or signal-induced proliferation-associated 1, is a gene that encodes a protein involved in cell signaling and proliferation. The protein, also referred to as SIPA1, functions primarily as a GTPase-activating protein (GAP) that inactivates RAP1, a member of the Ras-related protein family, thereby influencing various cellular processes such as cell adhesion, proliferation, and migration. SIPA1 is characterized by several functional domains, including a GAP-related domain, a PDZ domain, and a leucine zipper-like domain, which facilitate its interactions with other proteins and nucleic acids. It is expressed in various tissues, particularly within the lymphohematopoietic system, and plays a significant role in maintaining the homeostasis of the bone marrow niche. SIPA1's involvement in cancer progression, particularly in breast, lung, and prostate cancers, highlights its potential as a prognostic marker and therapeutic target (Xiao2018Sipa1; Liu2021SIPA1; Crawford2006Germline).

## Structure
The SIPA1 protein is a 130 kDa soluble protein involved in cell signaling and proliferation. It contains a GTPase-activating protein (GAP)-related domain, which is homologous to the catalytic region of Rap1GAP, playing a role in regulating tumor cell adhesion and invasion (Ma2021A). The protein's nuclear localization is determined by a specific region within its structure, particularly the 140-179 amino acid segment, which is crucial for its nuclear translocation. This region contains a histidine residue but lacks typical nuclear localization signal features, suggesting a novel mechanism for nuclear import (Ma2021A).

SIPA1 also functions as a transcription factor in triple-negative breast cancer, with a DNA-binding region (DBR) located between Ser764 and Ala864. This region contains several α-helices and β-sheets essential for DNA interaction, allowing SIPA1 to bind to specific DNA motifs and regulate gene transcription (Guo2023A). The protein can exist in multiple isoforms due to alternative splicing, which may affect its structure and function. SIPA1's interaction with importin β1 is necessary for its nuclear transport, highlighting its dynamic role in cellular processes (Guo2023A).

## Function
The SIPA1 gene encodes a RAP1 GTPase-activating protein that plays a crucial role in regulating signaling pathways involving integrins, growth factors, and cytokines by inactivating RAP1. In healthy human cells, SIPA1 is expressed in hematopoietic stem and progenitor cells (HSPCs) and lymphocytes, where it maintains the homeostasis of the bone marrow niche, essential for proper hematopoiesis (Xiao2018Sipa1). SIPA1 influences cell adhesion and the secretion of factors that determine hematopoietic stem cell fate, impacting interactions between these cells and their niche (Xiao2018Sipa1).

SIPA1 is composed of 1042 amino acids and contains several domains, including a RapGTPase-activating protein (GAP) related domain, a PDZ domain, and a leucine zipper-like domain, which are involved in protein interactions and dimerization (Liu2021SIPA1). It is expressed in various tissues, particularly in the lymphohematopoietic system, and can be located in the cytoskeleton, plasma membranes, and nuclei (Liu2021SIPA1). SIPA1's initial function was thought to be specific GAP activity for Ras-related proteins, but it primarily acts by inhibiting Rap1 activation, affecting cell adhesion (Liu2021SIPA1).

## Clinical Significance
The SIPA1 gene has been implicated in various cancers due to its role in cell signaling and proliferation. In lung cancer, particularly lung adenocarcinoma, high SIPA1 expression is associated with advanced disease stages and poorer clinical outcomes, such as shorter overall survival and progression-free survival. This suggests that SIPA1 may play a crucial role in tumorigenesis and metastasis, potentially serving as a prognostic marker and therapeutic target (Liu2021SIPA1).

In breast cancer, SIPA1 polymorphisms, such as -313G>A and 545C>T, are linked to aggressive disease characteristics, including lymph node involvement and hormone receptor-negative status. These polymorphisms may influence metastatic potential independently of tumor size, highlighting SIPA1's role in cancer progression (Crawford2006Germline). SIPA1 is also significantly upregulated in breast cancer tissues, correlating with increased metastatic potential (Xiang2022SIPA1).

In prostate cancer, high SIPA1 expression is linked to poor prognosis and increased metastasis, affecting cell adhesion to the extracellular matrix (Liu2021SIPA1). SIPA1's involvement in these cancers underscores its potential as a biomarker and therapeutic target in oncology.

## Interactions
SIPA1 interacts with various proteins and nucleic acids, playing a significant role in cancer progression and metastasis. It binds to the promoter of the MYH9 gene, leading to increased myosin-9 accumulation in extracellular vesicles, which enhances macrophage infiltration in the tumor microenvironment (Feng2022Extracellular). SIPA1 also interacts with integrin β1, affecting the FAK/Akt signaling pathway and influencing cell adhesion and invasion in breast cancer cells (Liu2020The).

In triple-negative breast cancer (TNBC), SIPA1 translocates to the nucleus in response to fibronectin, facilitated by its interaction with importin β1. This interaction is crucial for SIPA1's role as a transcription factor, where it binds to specific DNA motifs, such as TGAGTCAB, to regulate gene transcription (Guo2023A). SIPA1 also binds to the EPAS1 promoter, enhancing its transcription and promoting hypoxic responses and aerobic glycolysis in breast cancer cells (Yao2022SIPA1).

SIPA1's interaction with BRD4, a transcriptional coactivator, suggests a role in modulating transcriptional activity and promoting cancer progression. It also upregulates SMAD2 and SMAD3, which are associated with cancer cell stemness and chemoresistance (Wang2020SIPA1).


## References


[1. (Feng2022Extracellular) Lingyun Feng, Jun Weng, Chenguang Yao, Ruyuan Wang, Ning Wang, Yilei Zhang, Yoshimasa Tanaka, and Li Su. Extracellular vesicles derived from sipa1high breast cancer cells enhance macrophage infiltration and cancer metastasis through myosin-9. Biology, 11(4):543, March 2022. URL: http://dx.doi.org/10.3390/biology11040543, doi:10.3390/biology11040543. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biology11040543)

[2. (Ma2021A) Ying Ma, Jun Weng, Ning Wang, Yilei Zhang, Nagahiro Minato, and Li Su. A novel nuclear localization region in sipa1 determines protein nuclear distribution and epirubicin-sensitivity of breast cancer cells. International Journal of Biological Macromolecules, 180:718–728, June 2021. URL: http://dx.doi.org/10.1016/j.ijbiomac.2021.03.101, doi:10.1016/j.ijbiomac.2021.03.101. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ijbiomac.2021.03.101)

[3. (Xiao2018Sipa1) Pingnan Xiao, Monika Dolinska, Lakshmi Sandhow, Makoto Kondo, Anne-Sofie Johansson, Thibault Bouderlique, Ying Zhao, Xidan Li, Marios Dimitriou, George Z. Rassidakis, Eva Hellström-Lindberg, Nagahiro Minato, Julian Walfridsson, David T. Scadden, Mikael Sigvardsson, and Hong Qian. Sipa1 deficiency–induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm. Blood Advances, 2(5):534–548, March 2018. URL: http://dx.doi.org/10.1182/bloodadvances.2017013599, doi:10.1182/bloodadvances.2017013599. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1182/bloodadvances.2017013599)

[4. (Guo2023A) Lijuan Guo, Wanjun Zhang, Xue Zhang, Jun Wang, Jiaqi Nie, Xiaomeng Jin, Ying Ma, Shi Wang, Xinhong Zhou, Yilei Zhang, Yan Xu, Yoshimasa Tanaka, Jingping Yuan, Xing-Hua Liao, Yiping Gong, and Li Su. A novel transcription factor sipa1: identification and verification in triple-negative breast cancer. Oncogene, 42(35):2641–2654, July 2023. URL: http://dx.doi.org/10.1038/s41388-023-02787-3, doi:10.1038/s41388-023-02787-3. This article has 3 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-023-02787-3)

[5. (Wang2020SIPA1) Ning Wang, Jun Weng, Jing Xia, Yangjin Zhu, Qiongrong Chen, Die Hu, Xue Zhang, Rui Sun, Jueping Feng, Nagahiro Minato, Yiping Gong, and Li Su. Sipa1 enhances smad2/3 expression to maintain stem cell features in breast cancer cells. Stem Cell Research, 49:102099, December 2020. URL: http://dx.doi.org/10.1016/j.scr.2020.102099, doi:10.1016/j.scr.2020.102099. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.scr.2020.102099)

[6. (Liu2020The) Chang Liu, Wen Jiang, Rachel Hargest, and Tracey Martin. The role of sipa1 in the development of cancer and metastases (review). Molecular and Clinical Oncology, July 2020. URL: http://dx.doi.org/10.3892/mco.2020.2102, doi:10.3892/mco.2020.2102. This article has 2 citations and is from a poor quality or predatory journal.](https://doi.org/10.3892/mco.2020.2102)

[7. (Liu2021SIPA1) Chang Liu, Wenguo Jiang, Lijian Zhang, Rachel Hargest, and Tracey A. Martin. Sipa1 is a modulator of hgf/met induced tumour metastasis via the regulation of tight junction-based cell to cell barrier function. Cancers, 13(7):1747, April 2021. URL: http://dx.doi.org/10.3390/cancers13071747, doi:10.3390/cancers13071747. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13071747)

[8. (Crawford2006Germline) Nigel PS Crawford, Argyrios Ziogas, David J Peel, James Hess, Hoda Anton-Culver, and Kent W Hunter. Germline polymorphisms in sipa1are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Research, March 2006. URL: http://dx.doi.org/10.1186/bcr1389, doi:10.1186/bcr1389. This article has 90 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/bcr1389)

[9. (Yao2022SIPA1) Chenguang Yao, Jun Weng, Lingyun Feng, Wanjun Zhang, Yan Xu, Peijing Zhang, Yoshimasa Tanaka, and Li Su. Sipa1 enhances aerobic glycolysis through hif-2α pathway to promote breast cancer metastasis. Frontiers in Cell and Developmental Biology, January 2022. URL: http://dx.doi.org/10.3389/fcell.2021.779169, doi:10.3389/fcell.2021.779169. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.779169)

[10. (Xiang2022SIPA1) Yuan Xiang, Lingyun Feng, Hui Liu, Yuhuan Liu, Jiapeng Li, Li Su, and Xinghua Liao. Sipa1 regulates linc01615 to promote metastasis in triple-negative breast cancer. Cancers, 14(19):4815, October 2022. URL: http://dx.doi.org/10.3390/cancers14194815, doi:10.3390/cancers14194815. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers14194815)